PKHD1 and autosomal recessive polycystic kidney disease: Our results suggested that ASOs may be a new option for ARPKD patients with aberrant splicing, as all of the ASOs could effectively rescue the splicing abnormalities caused by the c.2141-3T>C mutation of the PKHD1 gene in vitro.